152
Participants
Start Date
October 31, 2013
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Fragmin
variable dosing regimen
Royal Alexandra Hospital, Edmonton
University of Alberta Hospital, Edmonton
Grey Nuns Community Hospital, Edmonton
Horizon Health Network/Saint John Regional Hospital, Saint John
Eastern Regional Health Authority, Health Sciences Centre, St. John's
Eastern Regional Health Authority, St. Clare's Mercy Hospital, St. John's
Eastern Regional Health Authority, Waterford Hospital, St. John's
Queen Elizabeth II Health Sciences Center (QEII) - VG Site, Halifax
William Osler Health System - Bramptom Civic Hospital, Brampton
London Health Sciences Centre, University Hospital, London
London Health Sciences Centre, Kidney Care Centre, London
William Osler Health System, Orangeville
Centre intégré de santé et de services sociaux de la Montérégie-Centre, Greenfield Park
Centre externe de néphrologie CISSS de la Montérégie-Centre, Greenfield Park
Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopital Saint-Luc, Montreal
CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal
CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal
CHU de Quebec (Pavillon Hotel-Dieu de Quebec), Québec
Centre externe de néphrologie CISSS de la Montérégie-Centre, Saint-Lambert
Lead Sponsor
Pfizer
INDUSTRY